SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MERIGHI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.012
AS - Asia 11.643
EU - Europa 6.710
SA - Sud America 1.770
Continente sconosciuto - Info sul continente non disponibili 343
AF - Africa 265
OC - Oceania 23
Totale 41.766
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 20.503
SG - Singapore 4.223
CN - Cina 3.006
DE - Germania 1.349
BR - Brasile 1.343
VN - Vietnam 1.275
IT - Italia 1.238
UA - Ucraina 1.014
HK - Hong Kong 946
TR - Turchia 758
GB - Regno Unito 652
FI - Finlandia 512
FR - Francia 447
SE - Svezia 378
RU - Federazione Russa 351
BD - Bangladesh 302
JP - Giappone 285
CA - Canada 275
PL - Polonia 273
IN - India 239
MX - Messico 165
AR - Argentina 157
NL - Olanda 128
ID - Indonesia 109
IQ - Iraq 98
ZA - Sudafrica 93
ES - Italia 83
CO - Colombia 58
EC - Ecuador 56
PK - Pakistan 56
LT - Lituania 51
BE - Belgio 49
VE - Venezuela 48
MA - Marocco 43
MY - Malesia 39
CL - Cile 38
SA - Arabia Saudita 38
UZ - Uzbekistan 34
AE - Emirati Arabi Uniti 32
PH - Filippine 26
PY - Paraguay 26
AT - Austria 24
TN - Tunisia 24
CZ - Repubblica Ceca 23
KE - Kenya 23
EG - Egitto 22
AU - Australia 19
IL - Israele 19
NP - Nepal 19
DZ - Algeria 18
JO - Giordania 17
KR - Corea 16
IE - Irlanda 15
PE - Perù 14
UY - Uruguay 14
BO - Bolivia 12
AL - Albania 11
PT - Portogallo 11
TW - Taiwan 11
CH - Svizzera 10
JM - Giamaica 10
RO - Romania 10
GR - Grecia 9
OM - Oman 9
TH - Thailandia 9
CR - Costa Rica 8
HN - Honduras 8
IR - Iran 8
NI - Nicaragua 8
RS - Serbia 8
AZ - Azerbaigian 7
BG - Bulgaria 7
ET - Etiopia 7
GT - Guatemala 7
HU - Ungheria 7
KG - Kirghizistan 7
SN - Senegal 7
EU - Europa 6
HR - Croazia 6
TT - Trinidad e Tobago 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
KZ - Kazakistan 5
LB - Libano 5
LV - Lettonia 5
MD - Moldavia 5
NG - Nigeria 5
NO - Norvegia 5
PA - Panama 5
PS - Palestinian Territory 5
SK - Slovacchia (Repubblica Slovacca) 5
SV - El Salvador 5
AM - Armenia 4
BH - Bahrain 4
BY - Bielorussia 4
CY - Cipro 4
GE - Georgia 4
MN - Mongolia 4
QA - Qatar 4
SY - Repubblica araba siriana 4
Totale 41.364
Salva come PNG Salva come JPEG
Città #
Singapore 2.758
Ashburn 2.242
Woodbridge 1.756
Fairfield 1.556
San Jose 1.433
Jacksonville 1.095
Chandler 1.077
Houston 1.063
Beijing 932
Hong Kong 926
Santa Clara 889
Ann Arbor 878
Seattle 665
Wilmington 643
Cambridge 533
Ho Chi Minh City 440
Dallas 437
Los Angeles 409
Izmir 366
Nanjing 336
Ferrara 320
Hanoi 312
New York 283
Tokyo 268
Council Bluffs 261
Princeton 255
Warsaw 245
Milan 230
Munich 220
Lauterbourg 219
Helsinki 217
Boardman 203
Shanghai 149
São Paulo 147
Dearborn 126
San Diego 116
Orem 113
Shenyang 111
Nanchang 105
London 100
Buffalo 97
Addison 90
Hefei 90
Mexico City 88
Tianjin 88
Montreal 87
Falkenstein 85
Bremen 82
Turku 80
Frankfurt am Main 76
Toronto 76
Jakarta 73
Brooklyn 68
Changsha 68
Chicago 67
Hebei 64
Da Nang 62
Chennai 60
Atlanta 59
San Francisco 57
Bologna 55
Denver 54
Haiphong 54
Jinan 49
Johannesburg 48
Manchester 48
Brussels 47
Jiaxing 46
Phoenix 45
Stockholm 44
Boston 43
Moscow 43
San Mateo 43
Poplar 42
Rome 42
Amsterdam 40
The Dalles 40
Baghdad 39
Falls Church 39
Rio de Janeiro 39
Kunming 36
Zhengzhou 36
Mountain View 35
Norwalk 33
Mumbai 32
Philadelphia 32
Guangzhou 31
Tashkent 31
Biên Hòa 27
Columbus 27
Auburn Hills 26
Ningbo 26
Ankara 25
Brasília 25
Redwood City 25
Charlotte 24
Belo Horizonte 23
Hải Dương 23
Medellín 23
Dhaka 21
Totale 27.412
Salva come PNG Salva come JPEG
Nome #
Pharmacology of Adenosine Receptors: The State of the Art 412
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 333
Caffeine alters A(2A) adenosine receptors and their function in human platelets 326
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 324
A glance at adenosine receptors: Novel target for antitumor therapy 312
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 303
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 290
The A3 adenosine receptor: history and perspectives 289
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 286
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 270
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 268
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 263
Adenosine receptors and human melanoma 258
Antioxidant and antiinflammatory effects of epilobium parviflorum, melilotus officinalis and cardiospermum halicacabum plant extracts in macrophage and microglial cells 258
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 254
[H-3]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors 252
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 251
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 247
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 247
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 244
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 244
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 237
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 237
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 236
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 230
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 229
Adenosine receptors and cancer 227
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 226
Adenosine receptor targeting in health and disease 224
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 221
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 219
van't Hoff Based Thermodynamics 219
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 218
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 217
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 217
Targeting A3 and A2A adenosine receptors in the fight against cancer 217
Pathological overproduction: the bad side of adenosine 216
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 215
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 214
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 214
Agonists and antagonists: Molecular mechanisms and therapeutic applications 214
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 213
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 210
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 208
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 208
Adenosine receptors in health and disease 208
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 208
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 207
Adenosine and lymphocyte regulation 206
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 205
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 205
Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A3 adenosine receptors. 204
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 202
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 202
[3H]-MRE 3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 202
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 202
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 201
New pyrrolo[2,1-f]purine-2,4-dione and imidazo[2,1-f]purine-2,4-dione derivatives as potent and selective human A(3) adenosine receptor antagonists 200
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 200
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 199
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 198
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour 197
A(2A) adenosine receptors in human peripheral blood cells 197
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 197
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 197
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 196
Adenosine modulates HIF-1, VEGF, IL-8 and foam cells formation in a human model of hypoxic foam cells 196
[3H]MRE3008-F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors. 196
A3 adenosine receptors in human neutrophils and promyelocitic HL60 cells: a pharmacological and biochemical study. 195
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 194
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 193
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 193
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 193
Adenosine in a human model of Hypoxic foam cells 191
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 191
Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells 188
Adenosine modulates HIF-1α, VEGF, IL-8, and foam cell formation in a human model of hypoxic foam cells 187
New potent and selective human adenosine A3 receptor antagonists. 186
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 185
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 184
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 184
[3H]-MRE 2029-F20, A Novel Selective Antagonist Radiolig and, for the Pharmacological and Biochemical Characterization of A2B Receptors. 182
Binding and functional parameters of A2A adenosine receptors in essential hypertensive patients before and after pharmacological treatment 182
MODULATION OF MMP-9 IN U87MG GLIOBLASTOMA CELLS BY A3 ADENOSINE RECEPTORS 182
L'ipossia inibisce l'apoptosi indotta da paclitaxel mediante fosforilazione di BAD dipendente dall'adenosina nelle cellule di glioblastoma. 180
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 180
New potent and selective human adenosine A3 receptor antagonists 180
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 179
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 179
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 179
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 179
Cannabinoid CB2 receptor modulates microglial cell activation: role of ERK-1/2 Kinase signaling. 179
The A3 adenosine receptor: An enigmatic player in cell biology 178
Recettori dell'adenosina in tessuti tumorali e in linee cellulari di colon:"focus" sul recettore A3. 178
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 178
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 177
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 177
Cytotoxic drugs regulate VEGF and IL-8 expression in human melanoma cells by A2A and A3 adenosine receptors. 177
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 176
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 176
Totale 21.704
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.151
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 7.083
Totale 184.234
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.157 45 228 152 75 84 97 81 104 76 183 322 710
2022/20232.535 245 223 91 337 424 325 140 203 291 24 143 89
2023/20241.272 113 168 44 27 131 139 53 93 32 54 65 353
2024/20255.622 128 192 419 289 701 522 246 315 741 638 786 645
2025/202616.100 1.635 571 1.351 1.978 2.329 1.110 1.903 797 1.611 1.788 637 390
2026/2027611 611 0 0 0 0 0 0 0 0 0 0 0
Totale 41.766